Expression of Lamininγ2 in Extrahepatic Cholangiocarcinoma Tissues and its Influence on Tumor Invasion and Metastasis |
Li, Yong
(Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University)
Li, Da-Jiang (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Chen, Jian (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Liu, Wei (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Li, Jian-Wei (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Jiang, Peng (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Zhao, Xin (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Guo, Fei (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Li, Xiao-Wu (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) Wang, Shu-Guang (Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University) |
1 | Degen M, Barron P, Natarajan E, et al (2013). RSK activation of translation factor eIF4B drives abnormal increases of laminin 2 and MYC protein during neoplastic progression to squamous cell carcinoma. PLoS One, 8, e78979. DOI |
2 | Fukuchi O, Suko A, Matsuzaki H, et al (2013). Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to 3, 3 and 2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site. J Dermatol, 40, 61-2. DOI |
3 | Huai JP, Ding J, Ye XH, et al (2014). Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a metaanalysis of population-based studies. Asian Pac J Cancer Prev, 15, 3477-82. DOI ScienceOn |
4 | Gasparoni A, Della Casa M, Milillo L, et al (2007). Prognostic value of differential expression of Laminin-5 gamma2 in oral squamous cell carcinomas: correlation with survival. Oncol Rep, 18, 793-800. |
5 | Imura J, Uchida Y, Nomoto K, et al (2012). Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma. Diagn Pathol, 7, 105. DOI |
6 | Kariya Y, Sato H, Katou N, et al (2012). Polymerized laminin-332 matrix supports rapid and tight adhesion of keratinocytes, suppressing cell migration. PLoS One, 7, e35546. DOI |
7 | Kim BG, Gao MQ, Choi YP, et al (2012). Invasive breast cancer induces laminin-332 upregulation and integrin neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling. Breast Cancer Res, 14, R88. DOI |
8 | Kinoshita T, Hanazawa T, Nohata N, et al (2012). Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget, 3, 1386-400. DOI |
9 | Kang SG, Ha YR, Ko YH, et al (2013). Effect of laminin 332 on motility and invasion in bladder cancer. Kaohsiung J Med Sci, 29, 422-9. DOI |
10 | Kamoshida G, Ogawa T, Oyanagi J, et al (2014). Modulation of matrix metalloproteinase-9 secretion from tumorassociated macrophage-like cells by proteolytically processed laminin-332 (laminin-5). Clin Exp Metastasis, 31, 285-91. DOI |
11 | Liu W, Tian F, Jiang P, et al (2014). Aberrant expression of laminin correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma. J Surg Res, 186, 150-6. DOI |
12 | Pattanathien P, Khuntikeo N, Promthet S, et al (2013). Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 321-4. DOI ScienceOn |
13 | Sato H, Oyanagi J, Komiya E, et al (2014). Amino-terminal fragments of laminin chain retract vascular endothelial cells and increase vascular permeability. Cancer Sci, 105, 168-75. DOI |
14 | Xue LY, Zou SM, Zheng S, et al (2011). Expressions of the chain of laminin-5 and secreted protein acidic and rich in cysteine in esophageal squamous cell carcinoma and their relation to prognosis. Chin J Cancer, 30, 69-78. DOI |
15 | Yang H, Zhou J, Wei X, et al (2014). Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor. Mol Clin Oncol, 2, 1069-75. |